HRP20231313T1 - Postupak dijagnosticiranja raka urogenitalnog sustava - Google Patents
Postupak dijagnosticiranja raka urogenitalnog sustava Download PDFInfo
- Publication number
- HRP20231313T1 HRP20231313T1 HRP20231313TT HRP20231313T HRP20231313T1 HR P20231313 T1 HRP20231313 T1 HR P20231313T1 HR P20231313T T HRP20231313T T HR P20231313TT HR P20231313 T HRP20231313 T HR P20231313T HR P20231313 T1 HRP20231313 T1 HR P20231313T1
- Authority
- HR
- Croatia
- Prior art keywords
- score
- biomarker gene
- indicates
- malignancy
- nrpm
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims 15
- 238000000034 method Methods 0.000 title claims 15
- 239000000090 biomarker Substances 0.000 claims 30
- 108090000623 proteins and genes Proteins 0.000 claims 25
- 201000011510 cancer Diseases 0.000 claims 17
- 230000035772 mutation Effects 0.000 claims 12
- 230000036210 malignancy Effects 0.000 claims 10
- 230000035945 sensitivity Effects 0.000 claims 10
- 231100000590 oncogenic Toxicity 0.000 claims 6
- 230000002246 oncogenic effect Effects 0.000 claims 6
- 206010060862 Prostate cancer Diseases 0.000 claims 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 4
- 230000004927 fusion Effects 0.000 claims 4
- 210000003734 kidney Anatomy 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 4
- 206010005003 Bladder cancer Diseases 0.000 claims 3
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 3
- 206010038389 Renal cancer Diseases 0.000 claims 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 3
- 201000010982 kidney cancer Diseases 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 238000012544 monitoring process Methods 0.000 claims 3
- 201000005112 urinary bladder cancer Diseases 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 2
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 1
- 102000008096 B7-H1 Antigen Human genes 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 208000006750 hematuria Diseases 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1814040.0A GB201814040D0 (en) | 2018-08-29 | 2018-08-29 | Testing and therapy |
| PCT/GB2019/052410 WO2020044046A2 (fr) | 2018-08-29 | 2019-08-29 | Test et thérapie |
| EP19779538.8A EP3844309B1 (fr) | 2018-08-29 | 2019-08-29 | Méthode de diagnostic des cancers du tractus génito-urinaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20231313T1 true HRP20231313T1 (hr) | 2024-02-16 |
Family
ID=63715249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20231313TT HRP20231313T1 (hr) | 2018-08-29 | 2019-08-29 | Postupak dijagnosticiranja raka urogenitalnog sustava |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220213550A1 (fr) |
| EP (1) | EP3844309B1 (fr) |
| ES (1) | ES2960872T3 (fr) |
| GB (1) | GB201814040D0 (fr) |
| HR (1) | HRP20231313T1 (fr) |
| HU (1) | HUE063906T2 (fr) |
| PL (1) | PL3844309T3 (fr) |
| WO (1) | WO2020044046A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113981078B (zh) * | 2021-09-16 | 2023-11-24 | 北京肿瘤医院(北京大学肿瘤医院) | 用于预测晚期食管癌患者抗egfr靶向治疗疗效的生物标志物及疗效预测试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1318504B1 (it) * | 2000-05-08 | 2003-08-27 | Talent Srl | Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina. |
| WO2015041788A1 (fr) * | 2013-09-23 | 2015-03-26 | The Johns Hopkins University | Mutations du promoteur tert dans la néoplasie urothéliale |
| WO2014159425A1 (fr) * | 2013-03-14 | 2014-10-02 | Myriad Genetics, Inc. | Détection et suivi du cancer de la vessie |
| WO2017085553A1 (fr) * | 2015-11-20 | 2017-05-26 | Mdxhealth Research B.V. | Méthode de prédiction et de traitement de cancers de la prostate cliniquement significatifs |
| WO2018027178A1 (fr) * | 2016-08-05 | 2018-02-08 | Emory University | Détection de mutations dans l'adn libre de cellules circulantes pour diagnostiquer un carcinome à cellules rénales |
-
2018
- 2018-08-29 GB GBGB1814040.0A patent/GB201814040D0/en not_active Ceased
-
2019
- 2019-08-29 US US17/272,130 patent/US20220213550A1/en active Pending
- 2019-08-29 ES ES19779538T patent/ES2960872T3/es active Active
- 2019-08-29 HU HUE19779538A patent/HUE063906T2/hu unknown
- 2019-08-29 PL PL19779538.8T patent/PL3844309T3/pl unknown
- 2019-08-29 HR HRP20231313TT patent/HRP20231313T1/hr unknown
- 2019-08-29 WO PCT/GB2019/052410 patent/WO2020044046A2/fr unknown
- 2019-08-29 EP EP19779538.8A patent/EP3844309B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE063906T2 (hu) | 2024-02-28 |
| WO2020044046A2 (fr) | 2020-03-05 |
| EP3844309C0 (fr) | 2023-07-19 |
| GB201814040D0 (en) | 2018-10-10 |
| ES2960872T3 (es) | 2024-03-07 |
| PL3844309T3 (pl) | 2024-01-03 |
| WO2020044046A3 (fr) | 2020-04-09 |
| EP3844309B1 (fr) | 2023-07-19 |
| EP3844309A2 (fr) | 2021-07-07 |
| US20220213550A1 (en) | 2022-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220259666A1 (en) | Assessment of the p13k cellular signaling pathway activity using mathematical modelling of target gene expression | |
| Guo et al. | Gene expression profile based classification models of psoriasis | |
| EP3729439B1 (fr) | Évaluation de l'activité de la voie de signalisation cellulaire mapk-ap 1 faisant appel à une modélisation mathématique de l'expression du gène cible | |
| CN105821042B (zh) | 人脐带血间充质干细胞基因组稳定性相关的miRNA及其应用 | |
| EP3692172B1 (fr) | Évaluation de l'activité de la voie de signalisation cellulaire jak-stat3 utilisant une modélisation mathématique de l'expression du gène cible | |
| CN110993104A (zh) | 肿瘤患者生存期预测系统 | |
| US20160002717A1 (en) | Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease | |
| CN111429968A (zh) | 用于预测肿瘤类型的方法、电子设备和计算机存储介质 | |
| Zhao et al. | Identification of pan-cancer prognostic biomarkers through integration of multi-omics data | |
| US20210327535A1 (en) | Sensitively detecting copy number variations (cnvs) from circulating cell-free nucleic acid | |
| Barefoot et al. | Detection of cell types contributing to cancer from circulating, cell-free methylated DNA | |
| US20190385697A1 (en) | Methods for predicting transcription factor activity | |
| KR101765999B1 (ko) | 암 바이오마커의 성능 평가 장치 및 방법 | |
| CN116200490A (zh) | 一种检测实体瘤微小残留病灶的方法 | |
| HRP20231313T1 (hr) | Postupak dijagnosticiranja raka urogenitalnog sustava | |
| US20130218581A1 (en) | Stratifying patient populations through characterization of disease-driving signaling | |
| CN114627970A (zh) | 结肠腺癌的焦亡相关lncRNA预后模型及其构建方法和应用 | |
| CN113862371A (zh) | 一种酒精相关性肝细胞癌疾病进展和预后风险的预测装置及其预测模型的训练方法 | |
| KR102161511B1 (ko) | 담도암 진단용 바이오마커의 추출 방법, 이를 위한 컴퓨팅 장치, 담도암 진단용 바이오마커 및 이를 포함하는 담도암 진단 장치 | |
| CN116434830B (zh) | 基于ctDNA多位点甲基化的肿瘤病灶位置识别方法 | |
| CN117438097B (zh) | 一种用于早期肝癌术后复发风险预测的方法及系统 | |
| Lyudovyk et al. | Pathway analysis of genomic pathology tests for prognostic cancer subtyping | |
| Akbar et al. | Unlocking Esophageal Carcinoma’s Secrets: An integrated Omics Approach Unveils DNA Methylation as a pivotal Early Detection Biomarker with Clinical Implications. | |
| WO2023247776A1 (fr) | Dispositif de détermination d'un indicateur de présence de hrd dans un génome d'un sujet | |
| CN117766025A (zh) | 骨肉瘤无肺转移生存预后的预测方法及装置、设备 |